Genetics of rheumatoid arthritis: Is there a pattern predicting extraarticular manifestations?

Arthritis Care and Research

Volumn 51, Issue 5, 2004, Pages 853-863

  Turesson, Carl ^a,b   Weyand, Cornelia M ^c   Matteson, Eric L ^a  

^a Mayo Clinic   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR2 ANTIGEN; HLA DR4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ALLELE; ANTIGEN PRESENTING CELL; CLINICAL FEATURE; DISEASE SEVERITY; GENE EXPRESSION; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION;

ARTHRITIS, RHEUMATOID; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHISM, GENETIC;

EID: 5644264892     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20693     Document Type: Review

References (148)

1. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002;29:62-7.
2. Gabriel SE, Crowson CS, Kremers HM, Doran MF, Turesson C, O'Fallon WM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum 2003;48:54-8.
3. Butnam S, Espinoza LR, Del Carpio J, Osterland CK. Rheumatoid pericarditis: rapid deterioration with evidence of local vasculitis. JAMA 1977;238:2394-6.
4. Vaugn DG, Asbury T, Riordan-Eva P. General ophthalmology. 13th ed. Norwalk (CT): Appleton & Lange; 1992.
5. Sokoloff L, McCluskey RT, Bunim JJ. Vascularity of the early subcutaneous nodule of rheumatoid arthritis. Arch Pathol 1953;55:475-95.
6. Westedt M-L, Vermeer B-J, Meijer CJL, Daha MR, Baldwin WM, Cats A. Immunopathological abnormalities in the normal skin of patients with rheumatoid arthritis in relation to clinical and serological findings: a one year follow up study. Ann Rheum Dis 1987;46:213-8.
7. Turesson C, Englund P, Jacobsson LT, Sturfelt G, Truedsson L, Nennesmo I, et al. Increased endothelial expression of HLA-DQ and interleukin 1alpha in extra-articular rheumatoid arthritis: results from immunohistochemical studies of skeletal muscle. Rheumatology (Oxford) 2001;40:1346-54.
8. Turesson C, Jacobsson L, Bergstrom U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford) 1999;38:668-74.
9. Gabriel S, Crowson CS, O'Fallon WM. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum 1999;42:415-20.
10. Batley A, Young A, Mayes C. The effect of extra-articular rheumatoid arthritis on prognosis [abstract]. Arthritis Rheum 2002;47 Suppl 9:S308.
11. Gordon DA, Stein JL, Broder I. The extraarticular manifestations of rheumatoid arthritis: a systemic analysis of 127 cases. Am J Med 1973;54:445-52.
12. Foster AC, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Ophthalmology 1984;91:1253-63.
13. Erhardt CC, Mumford PA, Venables PJW, Maini RN. Factors predicting the prognosis in rheumatoid arthritis: an eight year prospective study. Ann Rheum Dis 1989;48:7-13.
14. Hara KS, Ballard DJ, Ilstrup DM, Connolly DC, Vollertsen RS. Rheumatoid pericarditis: clinical features and survival. Medicine (Baltimore) 1990;69:81-91.
15. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis; incidence trends and risk factors over 46 years. Ann Rheum Dis 2003;62:722-7.
16. Aho K, Koskenvuo, Tuominen J, Kaprio J. Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 1986;13:899-902.
17. Silman AJ, MacGregor AJ, Thomson W, Holligan S, Carthy D, Farhan A, et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 1993;32:903-7.
18. Grant SFA, Thorleifsson G, Frigge ML, Thorsteinsson J, Gunnlaugsdottir B, Geirsson AJ, et al. The inheritance of rheumatoid arthritis in Iceland. Arthritis Rheum 2001;44:2247-54.
19. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000;43:30-7.
20. Stastny P. Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest 1976;57:1148-57.
21. Gibofsky A, Winchester R, Hansen J, Patarroyo M, Dupont B, Paget S, et al. Contrasting patterns of newer histocompatibility determinants in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 1978;21 Suppl 5:S134-8.
22. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
23. Williams RC, Jacobsson LTH, Knowler WC, del Puente A, Kostyu D, McAuley JE, et al. Meta-analysis reveals association between most common class II haplotype in full-heritage Native Americans and rheumatoid arthritis. Hum Immunol 1995;42:90-4.
24. Beasley RP, Willkens RF, Bennett PH. High prevalence of rheumatoid arthritis in Yakima Indians. Arthritis Rheum 1973;16:743-8.
25. Del Puente A, Knowler WC, Pettitt DJ, Bennett PH. High incidence and prevalence of rheumatoid arthritis in Pima Indians. Am J Epidemiol 1989;129:1170-8.
26. Deighton CM, Walker DJ, Griffiths ID, Roberts DF. The contribution of HLA to rheumatoid arthritis. Clin Genet 1989;36:178-82.
27. Cornelis F, Faure S, Martinez M, Prud'homme JF, Fritz P, Dib C, et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci U S A 1998;95:10746-50.
28. Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, Monteiro J, et al. A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet 2001;68:927-36.
29. Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, Etzel C, et al. Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. Arthritis Rheum 2003;48:906-16.
30. Shiozawa S, Hayashi S, Tsukamoto Y, Goko H, Kawasaki H, Wada T, et al. Identification of the gene loci that predispose to rheumatoid arthritis. Int Immunol 1998;10:1891-5.
31. Weyand CM, Hicok KC, Conn DL, Goronzy JJ. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992;117:801-6.
32. Gough A, Faint J, Salmon M, Hassell A, Wordsworth P, Pilling D, et al. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict clinical outcome. Arthritis Rheum 1994;37:1166-70.
33. Wagner U, Kaltenhauser S, Sauer H, Arnold S, Seidel W, Hantaschel H, et al. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. Arthritis Rheum 1997;40:341-51.
34. Koh W-H, Chan S-H, Lin Y-N, Boey M-L. Associations of HLA-DRB1 *0405 with extraarticular manifestations and erosions in Singaporean Chinese with rheumatoid arthritis. J Rheumatol 1997;24:629-32.
35. Salvarani C, Macchioni PL, Mantovani W, Bragliani M, Collina E, Cremonesi T, et al. HLA-DRB1 alleles associated with rheumatoid arthritis in northern Italy: correlations with disease severity. Br J Rheumatol 1998;37:165-9.
36. Combe B, Dougados M, Goupille P, Cantagrel A, Eliaou JF, Sibilia J, et al. Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. Arthritis Rheum 2001;44:1736-43.
37. Eberhardt K, Fex E, Johnson U, Wolheim FA. Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis. Ann Rheum Dis 1996;55:34-9.
38. Suarez-Almazor ME, Tao S, Moustarah F, Russel AS, Maksymowych V. HLA-DR1, DR4 and DRB1 disease related subtypes in rheumatoid arthritis: association with susceptibility but not severity in a city wide community based study. J Rheumatol 1995;22:2027-33.
39. Fries JF, Wolfe F, Apple R, Erlich H, Bugawan T, Holmes T, et al. HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias. Arthritis Rheum 2002;46:2320-9.
40. Ollier W, Venables PJW, Mumford PA, Maini RN, Awad J, Jaraquemada D, et al. HLA antigen associations with extraarticular rheumatoid arthritis. Tissue Antigens 1984;24:279-91.
41. Jaraquemada D, Ollier W, Awad J, Young A, Silman A, Roitt IM, et al. HLA and rheumatoid arthritis: a combined analysis of 440 British patients. Ann Rheum Dis 1986;45:627-36.
42. Lanchbury JSS, Jaeger EM, Sansom DM, Hall WA, Wordsworth P, Stereford J, et al. Strong primary selection for the Dw4 subtype of DR4 accounts for the HLA-DQw7 association with Felty's syndrome. Hum Immunol 1991;32:56-64.
43. Hillarby MC, Clarkson R, Grennan DM, Bate AS, Ollier W, Sanders PA, et al. Immunogenetic heterogenity in rheumatoid disease as illustrated by different MHC associations (DQ, Dw and C4) in articular and extraarticular subsets. Br J Rheumatol 1991;30:5-9.
44. Weyand CM, Xie C, Goronzy JJ. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 1992;89:2033-9.
45. Wordsworth P, Pile KD, Buckely JD, Lanchbury JS, Ollier B, Lathrop M, et al. HLA-heterozygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet 1992;51:585-91.
46. Salvarani C, Macchioni P, Mantovani W, Rossi F, Venezani M, Bioardi L, et al. Extraarticular manifestations of rheumatoid arthritis and HLA antigens in northern Italy. J Rheumatol 1992;19:242-6.
47. Agrawal S, Aggarwal A, Dabadghao S, Naik S, Misra R. Compound heterozygosity of HLA-DR4 and DR1 antigens in Asians increases the risk of extra-articular features in rheumatoid arthritis. Br J Rheumatol 1995;34:41-4.
48. Benazet JF, Reviron D, Mercier P, Roux H, Roudier J. HLA-DRB1 alleles associated with rheumatoid arthritis in southern France: absence of extraarticular disease despite expression of the shared epitope. J Rheumatol 1995;22:607-10.
49. MacGregor A, Ollier W, Thomson W, Jawaheer D, Silman A. HLA-DRB1 *0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. J Rheumatol 1995;22:1032-6.
50. Kim H-Y, Min J-K, Yang H-I, Park S-H, Hong Y-S, Jee W-H, et al. The impact of HLA-DRB1 *0405 on disease severity in Korean patients with seropositive rheumatoid arthritis. Br J Rheumatol 1997;36:440-3.
51. Hakala M, Silvennoinen-Kassinen S, Ikäheimo I, Isosomppi J, Tiilikainen A. HLA markers in a community based rheumatoid arthritis series. Ann Med 1997;29:291-6.
52. Gonzáles A, Nicovani N, Massardo L, Aguirre V, Cervilla V, Lanchbury JS, et al. Influence of HLA-DRB shared epitope on susceptibility to and severity of rheumatoid arthritis in Chilean patients. Ann Rheum Dis 1997;56:191-3.
53. Perdriger A, Chalés G, Semana G, Guggenbuhl P, Meyer O, Quillivic F, et al. Role of HLA-DR-DR and DR-DQ associations in the expression of extraarticular manifestations and rheumatoid factor in rheumatoid arthritis. J Rheumatol 1997;24:1272-6.
54. Voskuyl AE, Hazes JMW, Schreuder GMT, Schipper RF, de Vries RRP, Breedveld FC. HLA-DRB1, DQA1, and DQB1 genotypes and risk of vasculitis in patients with rheumatoid arthritis. J Rheumatol 1997;24:852-5.
55. Toussirot E, Auge B, Tiberghien P, Chabod J, Cedoz J-P, Wendung D. HLA-DRB1 alleles and shared amino sequences in disease susceptibility and severity in patients from eastern France with rheumatoid arthritis. J Rheumatol 1999;26:1446-51.
56. Turesson C, Jacobsson L, Bergström U, Truedsson L, Sturfelt G. Predictors of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 2000;29:358-64.
57. Mattey DL, Gonzales-Gay MA, Garcia-Porrua C, Thomson W, Hajeer AH, Ollier WE. Influence of HLA-DRB1 and microsatellite polymorphisms on the expression of extraarticular manifestations in rheumatoid arthritis from northwest Spain. Clin Exp Rheumatol 2001;19:703-8.
58. McKibbin M, Clark B, Isaacs JD, Morrell AJ, Griffiths B, Morgan AW, et al. Does the shared epitope genotype influence either the susceptibility to or the phenotype of corneal melting? Eye 2001;15:492-6.
59. Del Rincon I, Battafarano DF, Arroyo RA, Murphy FT, Escalante A. Heterogeneity between men and women in the influence of the HLA-DRB1 shared epitope on the clinical expression of rheumatoid arthritis. Arthritis Rheum 2002;46:1480-8.
60. Ioannidis JPA, Tarassi K, Papadopoulos IA, Voulgari PV, Boki KA, Papasteriades CA, et al. Shared epitopes and rheumatoid arthritis: disease associations in Greece and meta-analysis of Mediterranean European populations. Semin Arthritis Rheum 2002;31:361-70.
61. Mattey DL, Dawes PT, Fisher J, Brownfield A, Thomson W, Hajeer AH. Nodular disease in rheumatoid arthritis: association with cigarette smoking and HLA-DRB1/TNF gene interaction. J Rheumatol 2002;29:2313-8.
62. Kim H-Y, Kim TG, Park SH, Lee SH, Cho CS, Han H. Predominance of HLA-DRB1 *0405 in Korean patients with rheumatoid arthritis. Ann Rheum Dis 1995;54:988-90.
63. Gorman JD, Criswell LA. The shared epitope and severity of rheumatoid arthritis. Rheum Dis Clin North Am 2002;28:59-78.
64. Mattey DL, Gonzales-Gay MA, Hajeer AH, Dababneh A, Thomson W, Garcia-Porrua C, et al. Association between HLA-DRB1 *15 and secondary Sjögren's syndrome in patients with rheumatoid arthritis. J Rheumatol 2000;27:2611-6.
65. Tokunaga NK, Noda R, Kaneoka H, Ogahara S, Murata T, Hiratsuka T, et al. Association between HLA-DRB1 * 15 and Japanese patients with rheumatoid arthritis complicated by renal involvement. Nephron 1999;81:165-71.
66. Coakley G, Brooks D, Iqbal M, Kondeatis E, Vaughan R, Loughran TP Jr, et al. Major histocompatibility complex haplotypic associations in Felty's syndrome and large granular lymphocyte syndrome are secondary to allellic association with HLA-DRB1 * 04. Rheumatology 2000;39:393-8.
67. Gorman JD, David-Vaudey E, Lum RF, Criswell LA. Compound heterozygosity and risk of extra-articular manifestations in rheumatoid arthritis [abstract]. Arthritis Rheum 2002;47 Suppl 9:S99.
68. So AKL, Warner CA, Sansom D, Walport MJ. DQβ polymorphism and genetic susceptibility to Felty's syndrome. Arthritis Rheum 1988;31:990-4.
69. Clarkson R, Bate AS, Grennan DM, Chattopadhyay C, Sanders P, Davis M, et al. DQw7 and the C4B null allele in rheumatoid arthritis and Felty's syndrome. Ann Rheum Dis 1990;49:976-9.
70. Zanelli E, Huizinga TW, Guerne PA, Vischer TL, Tiercy JM, Verduyn W, et al. An extended HLA-DQ-DR haplotype rather than DRBl alone contributes to RA predisposition. Immunogenetics 1998;48:394-401.
71. van der Horst-Bruinsma IE, Visser H, Hazes JM, Breedveld FC, Verduyn W, Schleuder GM, et al. HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. Hum Immunol 1999;60:152-8.
72. de Vries N, van Elderen C, Tijssen H, van Riel PL, van de Putte LB. No support for HLA-DQ encoded susceptibility in rheumatoid arthritis. Arthritis Rheum 1999;42:1621-7.
73. Brown JH, Jardetzky T, Saper MA, Samraouri B, Bjorkman PJ, Wiley DC. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature 1988;332:845-50.
74. Klareskog L, Forsum U, Scheynius A, Kabelitz D, Wigzell H. Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A 1982;79:3632-6.
75. Todd JA, Acha-Orbea H, Bell J-I, Chao N, Fronek Z, Jacob CO, et al. A molecular basis for MHC class II associated autoimmunity. Science 1988;240:1003-9.
76. Roudier J, Petersen J, Rhodes GH, Luka J, Carson DA. Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR β-1 chain and the Epstein-Barr virus glycoprotein gp 110. Proc Natl Acad Sci USA 1989;86:5104-8.
77. Albani S, Tuckwell JE, Esparza L, Carson DA, Roudier J. The susceptibility sequence to rheumatoid arthritis is a cross-reactive B cell epitope shared by the Escherichia coli heat shock protein dnaJ and the histocompatibility leukocyte antigen DRB10401 molecule. J Clin Invest 1992;89:327-31.
78. Walser-Kuntz DR, Weyand CM, Weaver AJ, O'Fallon WM, Goronzy JJ. Mechanisms underlying the formation of the cell receptor repertoire in rheumatoid arthritis. Immunity 1995;2:597-605.
79. Nanki T, Kohsaka H, Mizushima N, Ollier WE, Carson DA, Miyasaka N. Genetic control of T cell receptor BJ gene expression in peripheral lymphocytes of normal and rheumatoid arthritis monozygotic twins. J Clin Invest 1996;98:1594-601.
80. Berg LJ, Frank GD, Davis MM. The effects of MHC gene dosage and allelic variation on T cell receptor selection. Cell 1990;60:1043-53.
81. Weyand CM, Goronzy JJ. Functional domains on HLA-DR molecules: implications for the linkage of HLA-DR genes to different autoimmune diseases. Clin Immunol Immunopathol 1994;70:91-8.
82. Salvat S, Auger I, Rochelle L, Begovich A, Geburher L, Sette A, et al. Tolerance to a self-peptide from the third hypervariable region of HLA DRB1 * 0401 in rheumatoid arthritis patients and normal subjects. J Immunol 1994;153:5321-9.
83. Albani S, Keystone EC, Nelson JL, Ollier WE, La Cava A, Montemayor AC, et al. Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nat Med 1995;1:448-52.
84. Roudier J. Association of MHC and rheumatoid arthritis: association of RA with HLA-DR4: the role of repertoire selection. Arthritis Res 2000;2:217-20.
85. Wagner UG, Koetz K, Weyand CM, Goronzy JJ. Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci U S A 1998;95:14447-52.
86. Martens PB, Goronzy JJ, Schaid D, Weyand CM. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum 1997;40:1106-14.
87. Loughran TP Jr, Starkebaum G. Large granular lymphocyte leukemia: report of 38 cases and review of the literature. Medicine (Baltimore) 1987;66:397-405.
88. Roth S, Willcox N, Rzepka R, Mayer MP, Melchers I. Major differences in antigen-processing correlate with a single Arg71-Lys substitution in HLA-DR molecules predisposing to rheumatoid arthritis and with their selective interactions with 70-kDa heat shock chaperones. J Immunol 2002;169:3015-20.
89. Penzotti JE, Nepom G, Lybrand TP. Use of T cell receptor/HLA-DRB1 * 04 molecular modeling to predict site-specific interactions for the DR shared epitope associated with rheumatoid arthritis. Arthritis Rheum 1997;40:1316-26.
90. Gebe JA, Novak EJ, Kwok WW, Farr AG, Nepom GT, Buckner JH. T cell selection and differential activation on structurally related HLA-DR4 ligands. J Immunol 2001;167:3250-6.
91. Kerlan-Candon S, Louis-Plence P, Wiedemann A, Combe B, Clot J, Eliaou JF, et al. Specific overexpression of rheumatoid arthritis-associated HLA-DR alleles and presentation of low-affinity peptides. Arthritis Rheum 2001;44:1281-92.
92. Yen J-H, Moore BE, Nakajima T, Scholl D, Schaid DJ, Weyand CM, et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 2001;193:1159-67.
93. Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988;31:1041-5.
94. Feldmann M, Brennan M, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
95. Lipsky PE, van der Heijde DMFM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-602.
96. Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, et al. A comparison of etanercept and methotrexate in rheumatoid arthritis. N Engl J Med 2000;343:1586-93.
97. Kuryliszyn-Moskal A. Cytokines and soluble CD4 and CD8 molecules in rheumatoid arthritis: relationship to systemic vasculitis and microvascular capillaroscopic abnormalities. Clin Rheumatol 1998;17:489-65.
98. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A 1990;87:1233-7.
99. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turestskaya RL. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993;16:180-6.
100. Kaijzel EL, Bayley JP, van Krugten MV, Smith L, van de Linde P, Bakker AM, et al. Allele-specific quantification of tumor necrosis factor alpha (TNF) transcription and the role of promoter polymorphisms in rheumatoid arthritis patients and healthy individuals. Genes Immunol 2001;2:135-44.
101. Brinkman BMN, Huizinga TWJ, Kurban SS, van der Velde EA, Schreuder GMTh, Hazes JMW, et al. Tumor necrosis factor gene polymorphisms in rheumatoid arthritis: associations with susceptibility to, or severity of, disease? Br J Rheumatol 1997;36:516-22.
102. Kaijzel EL, van Krugten MV, Brinkman BMN, Huizinga TWJ, van der Straaten T, Hazes JMW, et al. Functional analysis of the human tumor necrosis factor a (TNF-α) promoter polymorphism related to joint damage in rheumatoid arthritis. Mol Med 1998;4:724-33.
103. Fabris M, Di Poi E, D'Elia A, Damanate G, Sinigaglia L, Ferraccioli G. Tumor necrosis factor-α polymorphism in severe and mild-moderate rheumatoid arthritis. J Rheumatol 2002;29:29-33.
104. Hajeer AH, Dababneh A, Makki RF, Thomson W, Poulton K, Gonzalez-Gay MA, et al. Different loci within the HLA-DR and TNF-regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients. Tissue Antigens 2000;55:319-25.
105. Martinez A, Fernandez-Arquero M, Pascual-Salcedo D, Conejero L, Alves H, Balsa A, et al. Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis. Arthritis Rheum 2000;43:1366-70.
106. Meyer JM, Han J, Moxley G. Tumor necrosis factor markers show sex-influenced association with rheumatoid arthritis. Arthritis Rheum 2001;44:286-95.
107. Castro F, Acevedo E, Ciusani E, Angulo JA, Wollheim FA, Sandberg-Wollheim M. Tumour necrosis factor microsatellites and HLA-DRB1 *, HLA-DQA1 *, and HLA-DQB1 * alleles in Peruvian patients with rheumatoid arthritis. Ann Rheum Dis 2001;60:791-5.
108. Pascual M, Mataran L, Jones G, Shing D, van der Slik AR, Giphart MJ, et al. HLA haplotypes and susceptibility to rheumatoid arthritis: more than class II genes. Scand J Rheumatol 2002;31:275-8.
109. Field M, Gallagher G, Eskalde J, McGarry F, Richards SD, Munro R, et al. Tumor necrosis factor locus polymorphisms in rheumatoid arthritis. Tissue Antigens 1997;50:303-7.
110. Mattey DL, Hassel AB, Dawes PT, Ollier WE, Hajeer A. Interaction between tumor necrosis factor microsatellites and the HLA-DRB1 shared epitope in rheumatoid arthritis. Arthritis Rheum 1999;42:2698-704.
111. Mu H, Chen JJ, Jiang Y, King M-C, Thomson G, Criswell LA. Tumor necrosis factor a microsatellite polymorphism is associated with rheumatoid arthritis severity through an interaction with the HLA-DRB1 shared epitope. Arthritis Rheum 1999;42:438-42.
112. Newton J, Brown MA, Mililcic A, Ackerman H, Darke C, Wilson JN, et al. The effect of HLA-DR on susceptibility to rheumatoid arthritis is influenced by the associated lymphotoxin α-tumor necrosis factor haplotype. Arthritis Rheum 2003;48:90-6.
113. John S, Myerscough A, Marlow A, Hajeer A, Silman A, Ollier W, et al. Linkage of cytokine genes to rheumatoid arthritis: evidence of genetic heterogeneity. Ann Rheum Dis 1998;57:361-5.
114. Jouvenne P, Chaudhary A, Buchs N, Giovine FS, Duff GW. Possible genetic association between interleukin-1 alpha gene polymorphism and the severity of chronic polyarthritis. Eur Cytokine Netw 1999;10:33-6.
115. Cox A, Camp NJ, Cannings C, di Giovine FS, Dale M, Worthington J, et al. Combined sib-TDT and TDT provide evidence for linkage of the interleukin-1 gene cluster to erosive rheumatoid arthritis. Hum Mol Genet 1999;8:1707-13.
116. Cantagrel A, Navaux F, Loubet-Lescoulie P, Nourhashemi F, Enault G, Abbal M, et al. Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 1999;42:1093-100.
117. Trifunovic-Cvetkovic J, Wållberg-Jonsson S, Stegmayr B, Rantapää-Dahlqvist S, Lefvert A-K. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-α, IL-1β and IL-1Ra genes. J Rheumatol 2002;29:212-9.
118. Dewberry R, Holden H, Crossman D, Francis S. Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler Thromb Vasc Biol 2000;20:2394-400.
119. Nicklin MJ, Hughes DE, Barton JL, Ure JM, Duff GW. Arterial inflammation in mice lacking the type 1 interleukin receptor antagonist gene. J Exp Med 2000;191:303-12.
120. Ganrot PO, Laurell CB, Eriksson S. Obstructive lung disease and trypsin inhibitors in alpha-1-antitrypsin deficiency. Scand J Clin Lab Invest 1967;19:205-8.
121. Eriksson S. Discovery of alpha 1-antitrypsin deficiency. Lung 1990;168 Suppl:523-9.
122. Berg NO, Eriksson S. Liver disease in adults with alpha-1-antitrypsin deficiency. N Engl J Med 1972;287:1264-7.
123. Eriksson S. Alpha 1-antitrypsin deficiency and the liver. Acta Paediatr 1994;83:444-7.
124. Cox DW, Huber O. Rheumatoid arthritis and α-1antitrypsin. Lancet 1976;1:1216-7.
125. Buisseret PD, Pembrey ME, Lessof MH. α-1antitrypsin phenotypes in rheumatoid arthritis. Lancet 1997;2:1358-9.
126. Sjöblom KG, Wollheim FA. α-1-Antitrypsin phenotypes and rheumatic diseases. Lancet 1977;2:41-2.
127. Sanders PA, Thomson W, Browne DA, Dyer PA, Grennan DM. α-1-Antitrypsin (PI) allotypes in rheumatoid arthritis. Ann Rheum Dis 1986;45:450-3.
128. Geddes DM, Webley M, Brewerton DA. α-1-Antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis. Lancet 1977;2:1049-50.
129. Michalski JP, McCombs CC, Scopelitis E, Biundo JJ, Medsger TA. α-1-Antitrypsin phenotypes, including M subtypes, in pulmonary disease associated with rheumatoid arthritis and systemic sclerosis. Arthritis Rheum 1986;29:586-91.
130. Steers G, McMahon MJ, Grennan DM, Hillarby MC. Lack of association of the alpha-1-antitrypsin PIZ allele with rheumatoid arthritis or with its extra articular complications. Dis Markers 1992;10:151-7.
131. Elzouki AN, Segelmark M, Wieslander J, Eriksson S. Strong link between the alpha 1-antitrypsin PiZ allele and Wegener's granulomatosis. J Intern Med 1994;236:543-8.
132. Schmidt D, Goronzy JJ, Weyand CM. CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996;97:2027-37.
133. Abril A, Schaid D, Goronzy JJ, Weyand CM. Genetic factors influence the emergence of CD28 deficient CD4+ T cells and may represent novel disease risk genes for rheumatoid arthritis. Arthritis Rheum 1998;40:762.
134. Park W, Weyand CM, Schmidt D, Goronzy JJ. Costimulatory pathways controlling activity and peripheral tolerance in CD4+ CD28- T cells. Eur J Immunol 1997;27:1082-90.
135. Namekawa T, Snyder MR, Yen J-H, Goehring BE, Leibson PJ, Weyand CM, et al. Killer cell activating receptors function as co-stimulatory molecules on CD4 CD28 null T cells clonally expanded in rheumatoid arthritis. J Immunol 2000;165:1138-45.
136. Warrington KJ, Takemura S, Goronzy JJ, Weyand CM. CD4+ CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum 2001;44:13-20.
137. Liuzzo G, Kopecky SL, Frye RL, O'Fallon WM, Maseri A, Goronzy JJ, et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 1999;100:2135-9.
138. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000;102:2883-8.
139. Moosig F, Csernok E, Wang G, Gross WL. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin Exp Immunol 1998;114:113-8.
140. Nakajima T, Schulte S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ, et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 2002;105:570-5.
141. Uhrberg M, Valiante NM, Shum BP, Schilling HG, Lienert-Weidenbach K, Corliss B, et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997;7:753-63.
142. Moretta A, Sivori S, Vitale M, Pende L, Morelli R, Augugliaro R, et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules on human natural killer cells. J Exp Med 1995;182:875-84.
143. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995;268:405-8.
144. Vollertsen RS, Conn DL, Ballard DJ, Ilstrup DM, Kazmar RE, Silverfield JC. Rheumatoid vasculitis: survival and associated risk factors. Medicine (Baltimore) 1986;65:365-75.
145. Weyand CM, Schmidt D, Wagner U, Goronzy JJ. The influence of sex on the phenotype in rheumatoid arthritis. Arthritis Rheum 1998;41:817-22.
146. Struthers GR, Scott DL, Delamere JP, Shepheard H, Kitt M. Smoking and rheumatoid vasculitis. Rheumatol Int 1981;1:145-6.
147. Harrison BJ, Silman AJ, Wiles NJ, Scott DGI, Symmons DPM. The association of cigarette smoking with disease outcome in patients with early inflammatory disease. Arthritis Rheum 2001;44:323-30.
148. Hersey P, Prendergast D, Edwards A. Effects of cigarette smoking on the immune system. Med J Aust 1983;2:425-9.